Beta Adrenergic Signaling Promotes Drug Resistance in Sarcomas
2016-04-29
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Beta Adrenergic Signaling Promotes Drug Resistance in Sarcomas
Authors
Published Date
2016-04-29
Publisher
Type
Presentation
Abstract
Tumor cells often hijack metabolic pathways to promote tumor growth and chemoresistance. Recent studies by our group show that human angiosarcomas and canine hemangiosarcomas express β-adrenergic receptors (β-ARs). Treatment with β-AR antagonists (beta blockers) inhibited tumor growth and sensitized cells to chemotherapy agents. Because β-ARs modulate the expression of the co-transcription factor PGC-1α, a key regulator of gluconeogenesis, mitochondrial metabolism, and fatty acid oxidation, expression of PGC-1α may be essential for sarcoma growth. Furthermore, chemoresistance has been shown to induce PGC-1α-dependent increases in mitochondrial metabolism and promote tumor cell survival, leading us to hypothesize that knockdown of PGC-1α would mimic the effects of beta blockade and increase the sensitivity of angiosarcoma and hemangiosarcoma cells to chemotherapy. We found that non-specific and receptor-specific β-AR antagonists reduced the viability of AS5 cells; however, an inhibitor specific for the β3-AR reduced viability to the greatest extent. Treatment of AS5 cells with the generic beta blocker, propranolol, and the chemotherapy drug, doxorubicin, sensitized AS5 cells to chemotherapy when compared to doxorubicin treatment alone. Propranolol also reduced the expression of PGC-1α, and knockdown of PGC-1α with siRNAs reduced the expression of the co-transcription factor. Our data suggest that β-AR signaling is important for angiosarcoma cell viability, and that beta blockers used in combination with standard-of-care chemotherapies may increase therapeutic efficacy. Knockdown of PGC-1α in angiosarcoma and hemangiosarcoma cell lines followed by treatment with doxorubicin will need to be performed to confirm the role of PGC-1α in chemoresistance.
Keywords
Description
Related to
Replaces
License
Series/Report Number
Funding information
This research was supported by CFANS Research Apprenticeship Program, Sarcoma Foundation of America, Morris Animal Foundation, and the Undergraduate Research Opportunities Program (UROP).
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Fox, Kathryn; Dickerson, Erin. (2016). Beta Adrenergic Signaling Promotes Drug Resistance in Sarcomas. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/179885.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.